NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-181-2019-0-JP-04 Chimeric Antigen Receptors Containing Glypican 2 Binding Domains JP National Stage 2022-503413 Pending
NCI E-181-2019-0-PCT-02 Chimeric Antigen Receptors Containing Glypican 2 Binding Domains PCT PCT PCT/US2020/042469 Expired
NHGRI E-212-2020-0-US-02 System And Method For Estimating A Quantity Of Interest Based On An Image Of A Histological Section US ORD 16/251,730 Pending
NEI E-212-2015-0-US-08 METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS US CON 16/931,003 Pending
NHGRI E-212-2020-2-US-01 System And Method For Estimating A Quantity Of Interest Based On An Image Of A Histological Section US CIP 16/930,602 Pending
NIAID E-531-2013-2-US-07 EPSTEIN-BARR VIRUS VACCINES US DIV 16/922,322 Pending
NIAID E-154-2017-0-US-04 NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE US National Stage 16/959,644 11976109 Issued PDF
NCI E-103-2019-0-CN-05 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE CN National Stage 202080055447.2 Issued
NCI E-230-2012-0-JP-60 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 JP DIV 2020-114090 Issued
NCI E-103-2019-0-PCT-02 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE PCT PCT PCT/US2020/040544 Expired
NCI E-103-2019-0-EP-06 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE EP National Stage 20745396.0 Pending
NCI E-103-2019-0-JP-10 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE JP National Stage 2022-500090 Pending
NCI E-103-2019-0-MX-12 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE MX National Stage MX/a/2022/000174 Issued
NCI E-103-2019-0-EA-15 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE EA National Stage 202290208 Issued
NCI E-103-2019-0-AU-03 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE AU National Stage 2020299382 Pending
NCI E-103-2019-0-CA-04 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE CA National Stage 3142833 Pending
NCI E-103-2019-0-IL-08 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE IL National Stage 289488 Issued
NCI E-103-2019-0-IN-09 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE IN National Stage 202217002368 Issued
NCI E-103-2019-0-KR-11 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE KR National Stage 10-2022-7003667 Issued
NCI E-103-2019-0-SG-14 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE SG National Stage 11202114486Y Issued
NCI E-494-2013-0-CN-20 Methods of Preparing Anti-human Papillomavirus Antigen T Cells CN DIV 202010606868.1 Pending
NCI E-227-2017-0-US-04 PURIFICATION AND LABELING OF EXTRACELLULAR VESICLES USING A MIXED MODE RESI COMPOSITION US National Stage 16/959,071 Pending
NCI E-239-2017-0-EA-08 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS EA National Stage 202091335 Issued
NCI E-239-2017-0-BY-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS BY EA 202091335 Issued
NCI E-239-2017-0-RU-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS RU EA 202091335 Issued
NCI E-135-2019-0-TW-03 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 TW ORD 109121744 Pending
NHGRI E-104-2019-0-PCT-02 SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOLXYLASE ALPHA PCT PCT PCT/US2020/039901 Expired
NCI E-135-2019-0-PCT-02 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 PCT PCT PCT/US2020/039785 Expired
NIAID E-139-2006-0-US-67 DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS US DIV 16/912,359 11332722 Issued PDF
NCI E-142-2014-0-US-06 METHODS OF TREATMENTS USING ANTIGEN-BINDING PROTEINS TARGETING CD56 US DIV 16/912,291 Pending
NEI E-192-2014-1-US-08 Surgical Tool And Method For Soft Ocular Tissue Transplantation US CON 16/910,388 11723799 Issued PDF
NCI E-021-2015-0-JP-33 Anti-CD70 Chimeric Antigen Receptors JP DIV 2020-109158 Issued
NCI E-208-2015-0-US-08 THALIDOMIDE ANALOGS AND METHODS OF USE US CON 16/910,708 10836721 Issued PDF
NCI E-210-2020-0-PCT-01 High ASS1 Expressing Tumors Embody A Purine Rich Genomic Signature And Sensitivity To Purine Depletion PCT PCT PCT/IL2020/050708 Expired
NCATS E-757-2013-2-US-07 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES AS 12-LIPOXYGENASE INHIBITORS US DIV 16/909,712 11274077 Issued PDF
NIAID E-188-2015-0-US-05 POLYMER ADJUVANT US CON 16/907,912 Pending
NEI E-284-2012-2-US-09 METHODS AND COMPOSITIONS FOR TREATING GENETICALLY LINKED DISEASES OF THE EYE US National Stage 16/956,976 Abandoned
NCI E-021-2015-0-US-31 ANTI-CD70 CHIMERIC ANTIGEN RECEPTORS US DIV 16/906,061 Pending
NEI E-070-2019-0-EP-05 INTERLEUKIN-27 PRODUCING B-CELL POPULATION AND USES THEREOF EP National Stage 20736554.5 Pending
NEI E-070-2019-0-PCT-02 INTERLEUKIN-27 PRODUCING B-CELL POPULATION AND USES THEREOF PCT PCT PCT/US20/38368 Expired
NEI E-070-2019-0-JP-06 INTERLEUKIN-27 PRODUCING B-CELL POPULATION AND USES THEREOF JP National Stage 2021-575486 Pending
NEI E-070-2019-0-CA-04 INTERLEUKIN-27 PRODUCING B-CELL POPULATION AND USES THEREOF CA National Stage 3143998 Pending
NEI E-070-2019-0-AU-03 INTERLEUKIN-27 PRODUCING B-CELL POPULATION AND USES THEREOF AU National Stage 2020295470 Pending
NINDS E-088-2018-1-US-13 HERV-K Antibody For Treatment Of ALS US CON 16/903,947 Pending
NHLBI E-064-2018-0-US-05 Inner Curvature Charge Concentration Device For Tissue Laceration US National Stage 16/954,710 Pending
NCI E-188-2017-1-US-02 PEPTIDE HYDROGELS AND USE THEREOF US National Stage 16/954,492 11661439 Issued PDF
NIAID E-007-2015-0-US-35 CD47-targeted Therapies For The Treatment Of Infectious Disease US CON 16/902,068 1123-06-07 Issued PDF
NCI E-171-2018-8-US-06 MODIFIED CELLS AND METHODS OF THERAPY US CON 16/900,368 11925664 Issued PDF
NCI E-025-2015-0-US-04 ANTI-CD133 MONOCLONAL ANTIBODIES AND RELATED COMPOSITIONS AND METHODS US DIV 16/900,596 11352435 Issued PDF
NCI E-171-2018-8-US-07 MODIFIED CELLS AND METHODS OF THERAPY US CON 16/900,372 11266692 Issued PDF